Cargando…

Sex Differences in the Presentation, Treatment, and Outcome of Patients With Familial Hypercholesterolemia

Detalles Bibliográficos
Autores principales:	Ryzhaya, Natalia, Cermakova, Lubomira, Trinder, Mark, Ruel, Isabelle, Coutinho, Thais, Genest, Jacques, Brunham, Liam R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483526/ https://www.ncbi.nlm.nih.gov/pubmed/34032141 http://dx.doi.org/10.1161/JAHA.120.019286

Ejemplares similares

Patient Perspectives Regarding Genetic Testing for Familial Hypercholesterolemia
por: Marchand, Miles, et al.
Publicado: (2021)

Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia
por: Trinder, Mark, et al.
Publicado: (2020)

Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease
por: Trinder, Mark, et al.
Publicado: (2020)

Genetic testing for familial hypercholesterolemia in Quebec, Canada: a single-centre retrospective cohort study
por: Guerin, Amanda, et al.
Publicado: (2023)

Sex Differences in Familial Hypercholesterolemia
por: Klevmoen, Marianne, et al.
Publicado: (2023)

Prediction of Familial Hypercholesterolemia in Patients at High Atherosclerotic Cardiovascular Disease Risk Using a Recently Validated Algorithm
por: Alothman, Latifah, et al.
Publicado: (2019)

Prevalence and Treatment of Familial Hypercholesterolemia and Severe Hypercholesterolemia in Older Adults in Ontario, Canada
por: Akioyamen, Leo E., et al.
Publicado: (2022)

Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease
por: Trinder, Mark, et al.
Publicado: (2020)

Familial Hypercholesterolemia: Present and Future Management
por: Sjouke, B., et al.
Publicado: (2011)

Past, Present, and Future of Familial Hypercholesterolemia Management
por: Rocha, Viviane Z., et al.
Publicado: (2021)

Familial Hypercholesterolemia Presenting as Cerebral Ischemia and Xanthoma
por: Jingjing, Yang, et al.
Publicado: (2022)

Collaboration between Family Physicians and Specialists in the Diagnosis and Management of Familial Hypercholesterolemia
por: Kotani, Kazuhiko
Publicado: (2021)

Cutaneous Xanthomas in a Young Child: Familial Hypercholesterolemia
por: Kumar, Sawan, et al.
Publicado: (2017)

Familial hypercholesterolemia presenting with multiple nodules of the hands and elbow
por: Maharaj, Satish, et al.
Publicado: (2015)

Genetic testing for familial hypercholesterolemia—past, present, and future
por: Futema, Marta, et al.
Publicado: (2021)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Homozygous familial hypercholesterolemia
por: Parihar, Ravi Kumar, et al.
Publicado: (2012)

Homozygous Familial Hypercholesterolemia
por: Nohara, Atsushi, et al.
Publicado: (2021)

Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2020)

Familial hypercholesterolemia and statins in the COVID-19 era: Mitigating the risk of ischemic stroke
por: Vuorio, Alpo, et al.
Publicado: (2021)

Reduced Lipoprotein(a) Associated With the Apolipoprotein E2 Genotype Confers Cardiovascular Protection in Familial Hypercholesterolemia
por: Blanchard, Valentin, et al.
Publicado: (2019)

The German CaRe high registry for familial hypercholesterolemia – Sex differences, treatment strategies, and target value attainment
por: März, Winfried, et al.
Publicado: (2023)

Identification of Docetaxel as a Potential Drug to Promote HDL Biogenesis
por: Choi, Hong Y., et al.
Publicado: (2021)

LDL apheresis in a woman with severe heterozygous familial hypercholesterolemia. Late, but not too late
por: Mickiewicz, Agnieszka, et al.
Publicado: (2015)

Opportunities for preventing further endothelial dysfunction in pregnant COVID-19 patients with familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2022)

Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19
por: Vuorio, Alpo, et al.
Publicado: (2021)

The Necessity of Collaboration With Doctors Involved in Annual Medical Checkups in the Identification of Familial Hypercholesterolemia in Japan
por: Kakehi, Eiichi, et al.
Publicado: (2022)

Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2022)

Familial Hypercholesterolemia: The Lipids or the Genes?
por: Fahed, Akl C, et al.
Publicado: (2011)

Familial hypercholesterolemia: A review
por: Varghese, Mithun J
Publicado: (2014)

Familial Hypercholesterolemia and the Atherosclerotic Disease
por: Kim, Yoo Ri, et al.
Publicado: (2013)

The Draupadi of dyslipidemia: Familial hypercholesterolemia
por: Kalra, Sanjay, et al.
Publicado: (2016)

Tendinous xanthoma with familial hypercholesterolemia
por: Roy, Alok Kumar, et al.
Publicado: (2014)

Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019)

Familial hypercholesterolemia: The skin speaks
por: Johnson, Johns T., et al.
Publicado: (2020)

Lipoprotein metabolism in familial hypercholesterolemia
por: Chemello, Kévin, et al.
Publicado: (2021)

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
por: Tandirerung, Fistra Janrio
Publicado: (2022)

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
por: Lima, Isabella Ramos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bfic6i2seu87dgagh410d42jot